Cyteir Therapeutics, Inc.

NASDAQ

CYT

Stock

Yield per half year: 0%
Dividend yield: 0%
Sector: Healthcare

Compare companies

Download the report:

Excel

Word

PDF

	Cyteir Therapeutics, Inc.	Gilead Sciences	Amgen
Capitalization
Price	3.02	114.15	288.47
Price priv.
Number of shares, million	35.27	1255	541
Capitalization, billion	0.0983	150.63	154.17
EBITDA, billion	-0.0482	4.43	13.36
EV, billion	-0.094	132.19	188.41
Profit and loss report
Net profit, billion	-0.0332	0.48	4.09
Revenue, bln, billion	0	28.75	33.42
EPS	-1.25	0.3825	7.56
Balance
Assets, bln, billion	0.1532	59	91.84
Debt, bln, billion	0.000889	26.71	60.1
Balance cost, billion	0.1463	19.33	5.88
Cash, bln, billion	0.1471	9.99	11.97
Coefficients
Dividend yield, %	0	3.08	3.07
Dividend	0	3.91	9.39
Dividend yield priv., %	0	0	0
Dividend priv.	0	0	0
Dividends/profit, %	0	816.25	118.14
P/S	0	4.02	4.2
P/BV	0.3569	6	23.87
P/E	0.34	240.57	34.3
Ev/Ebitda	1.95	29.81	14.11
Debt/Ebitda	-0.0184	6.02	4.5
Efficiency
ROE	-26.35	2.28	67.55
ROA	-25.21	0.7926	4.33
ROIC	-80.34	11.06	17
Ebitda margin	0	15.42	39.96
Net margin	0	1.67	12.24
Momentum
1 week, price changes	0 %	-1.26 %	-0.5373 %
1 month, price changes	0 %	-5.61 %	-0.4545 %
3 months, price changes	0 %	+4.73 %	+2.8 %
6 months, price changes	0 %	+5.95 %	+3.25 %
1 year, price changes	0 %	+22.01 %	+4.69 %
3 years, price changes	+127.07 %	+32.29 %	+8.09 %
5 years, price changes		+70.49 %	+20.59 %
10 years, price changes		+65.95 %	+71.35 %

More data >>

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe